Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation
NCT ID: NCT00219583
Last Updated: 2012-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
460 participants
INTERVENTIONAL
2004-08-31
2005-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
UK-390,957
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pfizer Investigational Site
Bondi Junction, New South Wales, Australia
Pfizer Investigational Site
St Leonards, New South Wales, Australia
Pfizer Investigational Site
Spring Hill, Queensland, Australia
Pfizer Investigational Site
Adelaide, South Australia, Australia
Pfizer Investigational Site
Malvern, Victoria, Australia
Pfizer Investigational Site
Nedlands, Western Australia, Australia
Pfizer Investigational Site
Mistelbach, , Austria
Pfizer Investigational Site
Salzburg, , Austria
Pfizer Investigational Site
Edmonton, Alberta, Canada
Pfizer Investigational Site
Victoria, British Columbia, Canada
Pfizer Investigational Site
London, Ontario, Canada
Pfizer Investigational Site
Oakville, Ontario, Canada
Pfizer Investigational Site
Toronto, Ontario, Canada
Pfizer Investigational Site
Montréal, Quebec, Canada
Pfizer Investigational Site
Montreal, Quebec, Canada
Pfizer Investigational Site
Brno, , Czechia
Pfizer Investigational Site
Hradec Králové, , Czechia
Pfizer Investigational Site
Prague, , Czechia
Pfizer Investigational Site
Le Kremlin-Bicêtre, , France
Pfizer Investigational Site
Lyon, , France
Pfizer Investigational Site
Munich, Bavaria, Germany
Pfizer Investigational Site
Hamburg, , Germany
Pfizer Investigational Site
Hanover, , Germany
Pfizer Investigational Site
München, , Germany
Pfizer Investigational Site
Beersheba, , Israel
Pfizer Investigational Site
Haifa, , Israel
Pfizer Investigational Site
Jerusalem, , Israel
Pfizer Investigational Site
Tel Aviv, , Israel
Pfizer Investigational Site
Tel Litwinsky, , Israel
Pfizer Investigational Site
Milan, , Italy
Pfizer Investigational Site
Roma, , Italy
Pfizer Investigational Site
Nijmegen, , Netherlands
Pfizer Investigational Site
The Hague, , Netherlands
Pfizer Investigational Site
Bodø, , Norway
Pfizer Investigational Site
Moelv, , Norway
Pfizer Investigational Site
Oslo, , Norway
Pfizer Investigational Site
Bialystok, , Poland
Pfizer Investigational Site
Kielce, , Poland
Pfizer Investigational Site
Mysłowice, , Poland
Pfizer Investigational Site
Warsaw, , Poland
Pfizer Investigational Site
Barcelona, Barcelona, Spain
Pfizer Investigational Site
Sabadell, Barcelona, Spain
Pfizer Investigational Site
Madrid, Madrid, Spain
Pfizer Investigational Site
Málaga, Malaga, Spain
Pfizer Investigational Site
Skövde, , Sweden
Pfizer Investigational Site
Stockholm, , Sweden
Pfizer Investigational Site
Balcali, Adana, Turkey (Türkiye)
Pfizer Investigational Site
Samanpazarı, Ankara, Turkey (Türkiye)
Pfizer Investigational Site
Balçova, İzmir, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A3871027
Identifier Type: -
Identifier Source: org_study_id